Plethora Solutions recommends GBP96m Regent Pacific offer
15th Dec 2015 13:57
(ShareCast News) - Plethora Solutions, which is developing a treatment for premature ejaculation, has agreed on a takeover by Hong Kong-listed Regent Pacific that values the AIM company at roughly £96m or 11.65p per share. At Regent Pacific's closing price on Monday, this valued Plethora at a level
Read morePlethora droops on increased losses
22nd Apr 2014 11:44
Shares in sexual health specialist Plethora Solutions drooped on news that the company made increased losses last year. On the upside, Plethora confirmed it has now settled on an "unambiguous defined path" for a successful submission for a US regulatory application for its lead product, 'PSD502', a
Read moreWednesday broker round-up UPDATE
12th Mar 2014 09:03
Ashtead Group: Citi raises target price from 850p to 1075p keeping a buy recommendation. Barratt Developments: Goldman Sachs reduces target price from 527p to 502p and downgrades to neutral. British Land: Jefferies downgrades to hold with a target price of 707p. Brooks Macdonald Group: Canaccord
Read morePlethora soars on drug development update
11th Mar 2014 10:20
Plethora Solutionas saw its value jump by around a third on Tuesday morning after it revealed a meeting with the US Food and Drug Administration (FDA) had resulted in a clear pathway to the successful submission of a new drug application. The application is for PSD 502, a drug used in the treatmen
Read morePlethora Solutions Chairman resigns
12th Apr 2013 11:50
Plethora Solutions Holdings Chairman Bill Robinson is stepping down from his role at the pharmaceuticals company. Jim Mellon will take over as Chairman with immediate effect temporarily until a successor is found. Robinson, who has been Chairman since 2009, will remain a Non-Executive Director of
Read morePlethora Solutions secures much needed financing
18th Mar 2013 14:25
Plethora Solutions has secured 2.1m pounds in funding after its subsidiary The Urology Co. fell into administration. The funds were raised through the placing of 106.2m new ordinary shares at a price of 2.0p per share, representing an 8.0% interest. It comes after the company announced it was in
Read morePlethora Solutions shares jump following new equity update
14th Feb 2013 08:24
Shares in pharmaceuticals company Plethora Solutions jumped sharply on Thursday after the group reported that it was in 'advanced discussions' with an investor to provide new equity financing to the group. The group, whose share price had recently been declining, added that support was also being s
Read morePlethora Solutions shares plunge on urgent financing talks
5th Feb 2013 11:07
Plethora Solutions is in urgent discussions with third parties to finance the company's working capital purposes. Shares in the pharmaceutical company plummeted 55.00% to 2.25p at 11:18 following Tuesday's announcement. The company said it remained focused on the development of SD502, a drug for
Read morePlethora's PSD502 drug has mass market potential
17th Oct 2012 15:15
Plethora Solutions is definitely a small cap stock to watch and in an exclusive interview with Sharecast, Daniel Stewart analyst Vadim Alexandre has reiterated the bull case for the biotech tiddler. Plethora Solutions has a drug, PSD502, aimed at treating premature ejaculation, which has passed two
Read moreSmall caps round-up: HMV, Corero, ANGLE ...
15th Mar 2012 12:06
HMV Group, the struggling entertainment media seller, has confirmed that it is still pondering what to do with its live music business. HMV added that a number of parties have indicated an interest in acquiring the business. There has been press speculation recently about who might be interested in
Read morePlethora's testosterone boost
14th Mar 2011 17:36
AIM-quoted sexual health products developer and distributor Plethora Solutions has added the pan-European rights for testosterone replacement treatment Striant SR to the UK rights it already has. Plethora has secured the rights from Columbia Laboratories and it will sell the product through its di
Read moreSmall caps round-up: Charlemagne, Highams, Hydro...
7th Sep 2010 13:48
Hedge fund manager Charlemagne's assets under management rise have picked up in the past two months to stand at $3.04bn at end August. The modest recovery follows a fall in the first half to $2.8bn, blamed on declining markets. Operating profits were $1.2m, down from $1.3m, with one-off performanc
Read morePlethora Solutions Launches New Product, hi-Argenol >PLE.LN
19th Jul 2010 07:25
LONDON (Dow Jones)--Plethora Solutions Holdings PLC (PLE.LN), a U.K.-based specialty pharmaceutical company, said Monday it has launched a new product, hi-Argenol, for the maintenance and improvement of male sexual health. -Shares closed Friday at 11.75 pence valuing the company at GBP5.21 milli
Read morePlethora Solutions Sees 1H In Line With Market Views, Revenue GBP1M
13th Jul 2010 07:28
LONDON (Dow Jones)--Plethora Solutions Holdings PLC (PLE.LN), the U.K.-based specialty pharmaceutical company, said Tuesday first half earnings are expected to be in line with analyst expectations with revenue for the six months ended June 30 of GBP1.0 million and of GBP1.4 million. MAIN FACTS:
Read moreUK SMALLCAP ROUNDUP: Scott Wilson Bidder URS Gets Deadline
30th Jun 2010 09:30
Dow Jones smallcap news is now on Twitter, allowing you to catch up on the news away from your desk. Go to http://twitter.com/DJ_UK_Smallcaps SCOTT WILSON GROUP PLC (SWG.LN), a U.K. engineering consultant, Wednesday said its board will give its recommendation to shareholders on the company's bi
Read more